Large data studies have revealed an elevated risk of PD in individuals with IBDs such as Crohn’s disease and ulcerative colitis [25, 26], while anti-tumor necrosis factor treatments that decrease gastrointestinal inflammation and improve intestinal permeability dysfunction can reduce the risk of developing PD [27]. The gene discussed is TNF; the disease is Parkinson disease.